Showing results (161-170 of 491) with videos related to

Sort By:
Pageof 50
American Heart Journal|July 22, 2009
The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromesShaun G Goodman, Wei Huang, Andrew T Yan, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 4, 2020
Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registriesZak Loring, Suchit Mehrotra, Jonathan P Piccini, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 15, 2024
Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA RegistryE Sebastian Debus, Victor Aboyans, Jackie Bosch, et al.
The American Journal of Medicine|January 9, 2007
Use of heparins in Non-ST-elevation acute coronary syndromesJoel M Gore, Frederick A Spencer, Robert J Goldberg, et al.
The Canadian Journal of Cardiology|April 11, 2016
A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk ScoreShamir R Mehta, John W Eikelboom, Purnima Rao-Melacini, et al.
Heart (British Cardiac Society)|November 23, 2007
The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trialM Henriksson, D M Epstein, S J Palmer, et al.
Circulation|December 27, 2011
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR)Peter Damman, Lars Wallentin, Keith A A Fox, et al.
American Heart Journal|December 13, 2005
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.
Circulation. Cardiovascular Quality and Outcomes|March 22, 2017
Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency CasesDarragh O'Neill, Owen Nicholas, Chris P Gale, et al.
Heart (British Cardiac Society)|January 18, 2014
Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003-2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR)C P Gale, V Allan, B A Cattle, et al.
Pageof 50